Exploring CAR T-Cell Therapy During the COVID-19 Pandemic: What’s on the Horizon for CAR T-Cell Therapies

This OncLive® webinar series will focus on the continued impact of the COVID-19 pandemic on the delivery of cellular therapeutics, particularly chimeric antigen receptor T cells. Join us Tuesday, June 2, 2020 at 8 PM EST.

Read the full article here

Related Articles